Source:http://linkedlifedata.com/resource/pubmed/id/12228766
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2002-9-13
|
pubmed:abstractText |
We evaluated the effects of the angiotensin-converting enzyme (ACE) inhibitor captopril on pathways for monocyte production of interleukin (IL)-1beta in vitro. Human monocytes were treated with captopril and stimulated with tumor necrosis factor (TNF)-alpha or lipopolysaccharide. Captopril caused a dose-dependent reduction of TNF-alpha induced IL-1beta. LPS-induced IL-1beta generation was not reduced by the ACE inhibitor. Pro-IL-1beta concentrations followed the same pattern as that for mature IL-1beta when monocytes were preincubated with captopril. Also, IL-1beta mRNA concentrations were reduced by captopril pretreatment in parallel with IL-1beta. We sought to determine whether captopril affected the nuclear factor (NF)-kappaB complex in monocytic cells. We found that the translocation of the p-65 component of NF-kappaB to the nucleus was inhibited by captopril. Thus captopril reduced TNF-alpha-induced IL-1beta and IL-1betamRNA synthesis in monocytes, in vitro, probably through interference with NF-kappaB activation of the IL-1beta gene. These results support the hypothesis that captopril has immunomodulating properties.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme...,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Captopril,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1,
http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-2143
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
140
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
103-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12228766-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:12228766-Antineoplastic Agents,
pubmed-meshheading:12228766-Captopril,
pubmed-meshheading:12228766-Dose-Response Relationship, Drug,
pubmed-meshheading:12228766-Gene Expression,
pubmed-meshheading:12228766-Humans,
pubmed-meshheading:12228766-Interleukin-1,
pubmed-meshheading:12228766-Monocytes,
pubmed-meshheading:12228766-NF-kappa B,
pubmed-meshheading:12228766-RNA, Messenger,
pubmed-meshheading:12228766-Tumor Necrosis Factor-alpha,
pubmed-meshheading:12228766-U937 Cells
|
pubmed:year |
2002
|
pubmed:articleTitle |
Captopril-impaired production of tumor necrosis factor-alpha-induced interleukin-1beta in human monocytes is associated with altered intracellular distribution of nuclear factor-kappaB.
|
pubmed:affiliation |
Center for Inflammatory and Hematology Research, Karolinska Institutet, Stockholm, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|